🔗 Share this article

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer laws, risking penalties, prosecution or prison.

Platform Reaction and Content Removal

According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one group, a vendor shared contact information, where most purchases take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these groups, messages show dark colored parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to possibly serious health risks”.